Arcellx, Inc. (ACLX)

69.11 -3.06 (-4.24%) USD  |  NASDAQ  |  Jan 21, 12:28
More

Arcellx Normalized Income (Quarterly)

Normalized Income (Quarterly) Chart

View Normalized Income (Quarterly) for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Income (Quarterly) Range, Past 5 Years

View Normalized Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Income (Quarterly) Benchmarks

View Normalized Income (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Amicus Therapeutics, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade